Daily Anesthesiology Research Analysis
Three impactful perioperative studies stand out today: a bench-to-bedside study demonstrates accurate photoacoustic breath monitoring of propofol for real-time anesthesia depth assessment; a 15-year trauma cohort links admission hypothermia after prehospital intubation to markedly worse outcomes; and a large liver transplant analysis shows higher neohepatic ALBI scores predict severe AKI, RRT, CKD, and graft failure.
Summary
Three impactful perioperative studies stand out today: a bench-to-bedside study demonstrates accurate photoacoustic breath monitoring of propofol for real-time anesthesia depth assessment; a 15-year trauma cohort links admission hypothermia after prehospital intubation to markedly worse outcomes; and a large liver transplant analysis shows higher neohepatic ALBI scores predict severe AKI, RRT, CKD, and graft failure.
Research Themes
- Breath-based anesthetic drug monitoring and depth-of-anesthesia assessment
- Trauma thermoregulation and consequences of prehospital intubation-related hypothermia
- Risk stratification after living-donor liver transplantation using neohepatic ALBI
Selected Articles
1. Photoacoustic detection of propofol in breath gas for monitoring depth of anaesthesia: from bench to bedside.
A newly developed photoacoustic sensor quantified propofol in breath by detecting sound waves emitted after optical excitation. Across test gases, bagged breath samples, and intraoperative real-time use, measurements showed high agreement with ion–molecule reaction mass spectrometry, demonstrating clinically accurate, noninvasive monitoring of propofol levels.
Impact: This work introduces a practical, accurate breath-based propofol monitor that could enable real-time titration of i.v. anesthesia and improve safety beyond current EEG surrogates.
Clinical Implications: Integration of breath propofol monitoring could support closed-loop TIVA control, reduce awareness and overdosing risk, and complement EEG-based depth indices in challenging cases.
Key Findings
- Photoacoustic sensing quantified propofol in breath with high agreement to ion–molecule reaction mass spectrometry in bench and clinical settings.
- Real-time intraoperative breath propofol monitoring was feasible in patients receiving propofol anesthesia.
- The technology offers a noninvasive, gas-phase biomarker for anesthesia depth assessment.
Methodological Strengths
- Direct head-to-head comparison against a reference standard (ion–molecule reaction mass spectrometry).
- Translational design spanning test gases, ex vivo breath samples, and real-time intraoperative measurements.
Limitations
- Sample size and external validation cohorts are not specified; multicenter validation is needed.
- Potential matrix effects (humidity, breath constituents) and device calibration stability require further study.
Future Directions: Prospective multicenter diagnostic accuracy studies linking breath propofol to plasma levels and outcomes; integration into closed-loop anesthesia systems and testing effects on awareness, hemodynamic stability, and recovery.
BACKGROUND: Ensuring adequate depth of i.v. anaesthesia by measuring propofol in breath gas could increase patient safety. Mass spectrometry, representing the reference standard of propofol breath gas measurements, is not feasible in routine clinical practice; hence, a photoacoustic sensor was developed. METHODS: The photoacoustic sensor quantifies propofol concentration in gas via the sound waves emitted by propofol molecules excited by light of specific wavelength and frequency. We studied the performance of the new sensor in propofol test gas, gas sampling bags filled with breath gas from different patients, and performed real-time measurements in patients undergoing propofol anaesthesia in comparison to ion-molecule reaction mass spectrometry. RESULTS: In test gas, photoacoustic and mass spectrometry correlated with an R CONCLUSIONS: Photoacoustic measurement of propofol concentration in breath gas is feasible with high accuracy in clinical applications.
2. Impact of neohepatic albumin-bilirubin scores on renal outcomes following living donor liver transplantation: a propensity score analysis.
In 2,171 LDLT recipients, higher neohepatic ALBI scores (≥ -1.615) strongly predicted severe AKI, need for RRT, 1-year CKD, and graft failure, consistent across multivariable and propensity-matched analyses. The findings position neohepatic ALBI as a practical, objective prognostic tool in the immediate post-transplant period.
Impact: Large-scale, methodologically rigorous analysis identifies a readily calculable perioperative biomarker to anticipate renal injury and graft outcomes, enabling targeted nephroprotection.
Clinical Implications: Use neohepatic ALBI to stratify AKI risk post-LDLT and tailor renoprotective bundles (hemodynamic goals, nephrotoxin avoidance, CRRT readiness), inform fluid/vasopressor strategies, and guide surveillance.
Key Findings
- Neohepatic ALBI ≥ -1.615 was associated with higher odds of severe AKI (multivariable OR 2.34; P<0.001; PSM OR 2.18).
- Risks of RRT (multivariable OR 3.80; P=0.008; PSM OR 7.17; P=0.010) and 1-year CKD (multivariable OR 1.22; P=0.044; PSM OR 1.43; P=0.006) increased with higher ALBI.
- Overall graft failure risk was higher with elevated ALBI (multivariable HR 1.30; P=0.041; PSM HR 1.55; P=0.018).
Methodological Strengths
- Large single-center cohort (n=2,171) with comprehensive outcomes.
- Convergent analyses (multivariable logistic/Cox models and propensity score matching) supporting robustness.
Limitations
- Observational design with potential residual confounding and center-specific practices.
- External validation and assessment of interventional thresholds are needed.
Future Directions: Prospective validation across centers; incorporation of ALBI into perioperative risk calculators; trials testing ALBI-guided renoprotective strategies on AKI and graft outcomes.
INTRODUCTION AND OBJECTIVES: Acute kidney injury (AKI) after liver transplantation (LT) impacts patient and graft outcomes. The Albumin-Bilirubin (ALBI) score, an objective and sensitive liver function index, may help predict post-LT outcomes. This study evaluated the association between neohepatic ALBI scores and renal outcomes in living donor LT (LDLT) recipients. PATIENTS AND METHODS: We examined 2171 adult LDLT recipients between 2012 and 2019. Outcomes included severe post-LT AKI, renal replacement therapy (RRT), chronic kidney disease (CKD) at 1 year, early allograft dysfunction (EAD), and overall graft failure. Multivariate logistic regression, Cox proportional hazards regression, and propensity score matched (PSM) analyses were performed to evaluate the association between neohepatic ALBI and post-LT outcomes. RESULTS: Severe AKI, RRT, CKD, EAD, and overall graft failure occurred in 21.6%, 2.2%, 41.9%, 5.9%, and 15.8% of patients, respectively. Higher neohepatic ALBI scores (≥-1.615) were significantly associated with severe AKI (OR: 2.34, 95% CI: 1.79-3.04, P<0.001, multivariate analysis; OR: 2.18, 95% CI: 1.62-2.95, P<0.001, PSM analysis), RRT (OR: 3.80, 95% CI: 1.53-11.31, P=0.008, multivariate analysis; OR: 7.17, 95% CI: 1.61-31.89, P=0.010, PSM analysis), CKD (OR: 1.22, 95% CI: 1.00-1.47, P=0.044, multivariate analysis; OR: 1.43, 95% CI: 1.11-1.85, P=0.006, PSM analysis), and overall graft failure (HR: 1.30, 95% CI: 1.01-1.68, P=0.041, multivariate analysis; HR: 1.55, 95% CI: 1.08-2.23, P=0.018, PSM analysis). CONCLUSIONS: Neohepatic ALBI scores are significantly associated with post-LT severe AKI, RRT, CKD, and graft failure, underscoring their prognostic value in LDLT recipients.
3. Admission Hypothermia in Trauma Patients Undergoing Prehospital Tracheal Intubation: 15-Year Review of a Level-1 Trauma Center.
Among 851 prehospital-intubated trauma patients, 43% were hypothermic on ED arrival. Lower ambient temperatures, helicopter transport, higher ISS, shock, acidosis, and coagulopathy independently predicted hypothermia, which was strongly associated with increased early and 30-day mortality, massive transfusion, longer ICU stay, and prolonged mechanical ventilation.
Impact: Quantifies the scope and consequences of hypothermia in a high-risk cohort and identifies actionable prehospital risk factors, informing targeted warming and monitoring protocols.
Clinical Implications: Implement aggressive prehospital and ED warming strategies for intubated trauma patients, monitor core temperature continuously, minimize exposure during transport, and integrate hypothermia risk into transfusion and damage control pathways.
Key Findings
- Admission hypothermia (<35°C) occurred in 43% (366/851) of prehospital-intubated trauma patients.
- Independent predictors included lower outside temperature, helicopter transport, higher ISS, shock, acidosis, and coagulopathy.
- Hypothermia was associated with higher 24-h and 30-day mortality, massive transfusion, longer ICU length of stay, and longer mechanical ventilation.
Methodological Strengths
- Large 15-year cohort with detailed multivariable analyses.
- Focus on a clinically important, high-risk subpopulation (prehospital-intubated trauma).
Limitations
- Single-center retrospective design with potential residual confounding.
- Causality cannot be inferred; warming interventions were not randomized or standardized.
Future Directions: Prospective evaluations of standardized prehospital warming protocols and randomized trials of active rewarming strategies to determine impact on mortality, transfusion needs, and ICU outcomes.
OBJECTIVES: The adverse role of accidental hypothermia in trauma patients has been studied for decades while patients undergoing prehospital tracheal intubation are at particular risk due to impaired temperature autoregulation. The primary objective of the study was to determine the prevalence and risk factors associated with admission hypothermia (body temperature <35 °C) at the emergency department. Secondary objectives included the assessment of the association of hypothermia with all-cause mortality, transfusion requirement, intensive care unit length of stay (ICU LOS), and duration of mechanical ventilation. METHODS: In a single-center retrospective analysis, trauma patients aged ≥16 years undergoing prehospital tracheal intubation were analyzed for admission temperature between 2008 and 2022. Multivariable logistic regression analyses and linear regression analyses were used to examine the association between risk factors, hypothermia, and outcomes. RESULTS: A total of 851 patients (72% male) with a median age of 50 years, a median injury severity score (ISS) of 27 points, and a 30-day mortality of 30% were included. The median admission body temperature was 35.1 °C, and 366 patients (43%) were hypothermic. Independent risk factors for hypothermia were outside temperature (OR 1.03 per one degree Celsius decrease, 95% CI 1.01 to 1.05), helicopter transport (OR 2.36, 95% CI 1.68 to 3.33), ISS score (OR 1.03, 95% CI 1.01 to 1.04), admission shock (OR 3.48, 95% CI 2.27 to 5.34), admission acidosis (OR 1.69, 95% CI 1.04 to 2.73), and admission coagulopathy (OR 1.85, 95% CI 1.25 to 2.76). Multivariable outcome analyses revealed significant associations of hypothermia with 24-h mortality (OR 6.6, 95% CI 3.2 to 13.64), 30-day mortality (OR 3.81, 95% CI 2.35 to 6.18), massive transfusion (OR 2.94, 95% CI 1.78 to 4.86), ICU LOS in survivors (beta weight 3.15, 95% CI 0.73 to 5.58) and duration of mechanical ventilation in survivors (beta weight 2.65, 95% CI 0.89 to 4.41). CONCLUSIONS: The present findings suggest that a significant proportion of trauma patients who require prehospital tracheal intubation experience hypothermia, which is associated with critical injury severity and high mortality rates. These associations suggest the potential for implementing preventive measures and rewarming strategies until arrival at the emergency department, necessitating further investigation.